Landos Biopharma, Inc.
LABPDelisted May 23, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001785345
Landos Biopharma, Inc. was delisted on May 23, 2024; its insiders filed their last Form 4 on May 23, 2024; 16 institutions reported holding it in 13F filings for Q1 2024, worth $34.9M in total; no superinvestor held it.
13F holders, Q1 2022
Institutional positions in Landos Biopharma, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 45
- +6 vs. Q4 2021
- Shares held
- 23.9M
- −1.04M (−4.2%) vs. Q4 2021
- Total value
- $35.3M
- −$84.5M (−70.6%) vs. Q4 2021
- New holders
- 9
- 12 more added
- Sold out
- 3
- 13 more reduced
1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LABP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 16 | $34.9M |
| Q4 2023 | 10 | $5.58M |
| Q3 2023 | 11 | $5.93M |
| Q2 2023 | 8 | $6.27M |
| Q1 2023 | 20 | $4.63M |
| Q4 2022 | 23 | $7.87M |
| Q3 2022 | 31 | $14.0M |
| Q2 2022 | 35 | $16.4M |
| Q1 2022 | 45 | $35.3M |
| Q4 2021 | 40 | $119.8M |
| Q3 2021 | 35 | $331.1M |
| Q2 2021 | 33 | $261.4M |
| Q1 2021 | 47 | $218.9M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Landos Biopharma, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 488 | $0 | 0.00% | −7,663−94.0% | Reduced |
| Wells Fargo & Company | 200 | $0 | 0.00% | +186+1,328.6% | Added |
| Acadian Asset Management LLC | 1,344 | $1.00K | 0.00% | −6,930−83.8% | Reduced |
| Legal & General Group Plc | 408 | $1.00K | 0.00% | 00.0% | Unchanged |
| Ameritas Investment Partners, Inc. | 515 | $1.00K | 0.00% | 00.0% | Unchanged |
| Manchester Capital Management LLC | 406 | $1.00K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 761 | $1.00K | 0.00% | +761 | New |
| Amalgamated Bank | 802 | $1.00K | 0.00% | +802 | New |
| Advisor Group Holdings, Inc. | 418 | $1.00K | 0.00% | +418 | New |
| Amalgamated Financial Corp. | 802 | $1.00K | 0.00% | +802 | New |
| FMR LLC | 1,383 | $2.00K | 0.00% | +1,383 | New |
| American International Group, Inc. | 2,324 | $3.00K | 0.00% | −163−6.6% | Reduced |
| California State Teachers Retirement System | 1,959 | $3.00K | 0.00% | +393+25.1% | Added |
| Deutsche Bank AG | 2,543 | $4.00K | 0.00% | −300−10.6% | Reduced |
| New York State Common Retirement Fund | 2,700 | $4.00K | 0.00% | −41−1.5% | Reduced |
| Citigroup Inc | 2,806 | $4.00K | 0.00% | +358+14.6% | Added |
| Allworth Financial LP | 5,286 | $8.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 5,974 | $9.00K | 0.00% | +2,002+50.4% | Added |
| Morgan Stanley | 7,260 | $11.0K | 0.00% | −146,516−95.3% | Reduced |
| Charles Schwab Investment Management Inc | 10,349 | $16.0K | 0.00% | −3,611−25.9% | Reduced |
| STRS Ohio | 11,400 | $16.0K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 16,982 | $25.0K | 0.00% | +4,003+30.8% | Added |
| D. E. Shaw & Co., Inc. | 16,988 | $25.0K | 0.00% | +16,988 | New |
| Goldman Sachs Group Inc | 19,537 | $29.0K | 0.00% | +1,969+11.2% | Added |
| Walleye Trading LLC | 33,132 | $49.0K | 0.00% | −10,147−23.4% | Reduced |
| Two Sigma Advisers, LP | 42,300 | $62.0K | 0.00% | +16,600+64.6% | Added |
| Northern Trust Corp | 45,696 | $67.0K | 0.00% | −311−0.7% | Reduced |
| Bank of America Corp | 56,321 | $83.0K | 0.00% | +25,096+80.4% | Added |
| Millennium Management LLC | 60,968 | $90.0K | 0.00% | +60,968 | New |
| Two Sigma Investments, LP | 73,651 | $109.0K | 0.00% | +18,873+34.5% | Added |
| Walleye Capital LLC | 93,533 | $138.0K | 0.00% | −11,675−11.1% | Reduced |
| State Street Corp | 110,196 | $163.0K | 0.00% | +2,600+2.4% | Added |
| Geode Capital Management, LLC | 113,455 | $167.0K | 0.00% | −469−0.4% | Reduced |
| Botty Investors LLC | 128,750 | $190.0K | 0.07% | 00.0% | Unchanged |
| Macquarie Group Ltd | 147,182 | $217.0K | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 159,001 | $234.0K | 0.00% | −145,797−47.8% | Reduced |
| Jacobs Levy Equity Management, Inc | 158,875 | $234.0K | 0.00% | +158,875 | New |
| Bridgeway Capital Management, LLC | 159,000 | $235.0K | 0.00% | +159,000 | New |
| OrbiMed Advisors LLC | 283,217 | $418.0K | 0.01% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 292,377 | $432.0K | 0.00% | −7,239−2.4% | Reduced |
| Renaissance Technologies LLC | 340,500 | $502.0K | 0.00% | +169,400+99.0% | Added |
| BlackRock Inc. | 520,308 | $767.0K | 0.00% | +49,880+10.6% | Added |
| OUP Management Co., LLC | 1,827,478 | $2.70M | 2.05% | 00.0% | Unchanged |
| RTW Investments, LP | 4,275,722 | $6.31M | 0.13% | 00.0% | Unchanged |
| Perceptive Advisors LLC | 14,869,915 | $21.9M | 0.46% | 00.0% | Unchanged |
| Logos Global Management LP | 0 | $0 | 0.00% | −1,375,000−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −15,200−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −3,805−100.0% | Sold out |
| Carroll Financial Associates, Inc. | – | – | – | – | Not filed |